Abstract:Human immunodeficiency virus type 1 (HIV-1) can be transmitted through breast-feeding and through contaminated blood donations. Copper has potent biocidal properties and has been found to inactivate HIV-1 infectivity. The objective of this study was to determine the capacity of copper-based filters to inactivate HIV-1 in culture media. Medium spiked with high titers of HIV-1 was exposed to copper oxide powder or copper oxide-impregnated fibers or passed through copper-based filters, and the infectious viral ti… Show more
“…Tested in simulated breathing conditions (28Á3 l min À1 ), no infectious viral particle was recovered from the copper oxide containing masks after 30 min, unlike with the control masks. In the same way, Borkow et al (2008) demonstrated the effectiveness of copper during HIV-1 passage through filters containing copper oxide powder or copper oxide-impregnated fibres (Borkow et al 2008). HIV-1 is inactivated when exposed to copper oxide in a dose-dependent manner, without neither cytotoxicity nor strain specificity.…”
Section: Copper As An Antiviral Surface Agentmentioning
confidence: 88%
“…() demonstrated the effectiveness of copper during HIV‐1 passage through filters containing copper oxide powder or copper oxide‐impregnated fibres (Borkow et al . ). HIV‐1 is inactivated when exposed to copper oxide in a dose‐dependent manner, without neither cytotoxicity nor strain specificity.…”
With the emergence of antibiotic resistance, the interest for antimicrobial agents has recently increased again in public health. Copper was recognized in 2008 by the United States Environmental Protection Agency (EPA) as the first metallic antimicrobial agent. This led to many investigations of the various properties of copper as an antibacterial, antifungal and antiviral agent. This review summarizes the latest findings about 'contact killing', the mechanism of action of copper nanoparticles and the different ways micro-organisms develop resistance to copper.
“…Tested in simulated breathing conditions (28Á3 l min À1 ), no infectious viral particle was recovered from the copper oxide containing masks after 30 min, unlike with the control masks. In the same way, Borkow et al (2008) demonstrated the effectiveness of copper during HIV-1 passage through filters containing copper oxide powder or copper oxide-impregnated fibres (Borkow et al 2008). HIV-1 is inactivated when exposed to copper oxide in a dose-dependent manner, without neither cytotoxicity nor strain specificity.…”
Section: Copper As An Antiviral Surface Agentmentioning
confidence: 88%
“…() demonstrated the effectiveness of copper during HIV‐1 passage through filters containing copper oxide powder or copper oxide‐impregnated fibres (Borkow et al . ). HIV‐1 is inactivated when exposed to copper oxide in a dose‐dependent manner, without neither cytotoxicity nor strain specificity.…”
With the emergence of antibiotic resistance, the interest for antimicrobial agents has recently increased again in public health. Copper was recognized in 2008 by the United States Environmental Protection Agency (EPA) as the first metallic antimicrobial agent. This led to many investigations of the various properties of copper as an antibacterial, antifungal and antiviral agent. This review summarizes the latest findings about 'contact killing', the mechanism of action of copper nanoparticles and the different ways micro-organisms develop resistance to copper.
“…Many sterilization and filtration processes have been devised that can effectively remove or reduce HIV viral infectivity (268–273). Unfortunately, most of these technologies require tools not commonly available in households in developing countries or are prohibitively expensive.…”
Summary
The global spread of human immunodeficiency virus (HIV) is dependent on the ability of this virus to efficiently cross from one host to the next by traversing a mucosal membrane. Unraveling how mucosal exposure of HIV results in systemic infection is critical for the development of effective therapeutic strategies. This review focuses on understanding the immune events associated with the oral route of transmission (via breastfeeding or sexual oral intercourse), which occurs across the oral and/or gastrointestinal mucosa. Studies in both humans and simian immunodeficiency virus (SIV) monkey models have identified viral changes and immune events associated with oral HIV/SIV exposure. This review covers our current knowledge of HIV oral transmission in both infants and adults, the use of SIV models in understanding early immune events, oral immune factors that modulate HIV/SIV susceptibility (including mucosal inflammation), and interventions that may impact oral HIV transmission rates. Understanding the factors that influence oral HIV transmission will provide the foundation for developing immune therapeutic and vaccine strategies that can protect both infants and adults from oral HIV transmission.
“…La elaboración de filtros con óxido de cobre ha permitido eliminar en forma eficiente el riesgo de transmisión de VIH a través de fluidos 14 . Los mecanismos involucrados en la actividad antiviral son la inactivación de una enzima proteasa importante para la replicación viral y daño a nivel de la envoltura fosfolipídica [14][15][16] .…”
Section: Actividad Antiviral Del Cobreunclassified
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.